Metraipolis › archive › dc_ca0bea525946

The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection — Europe PMC PMID:41278310

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41278310
DOI: 10.1016/j.ekir.2025.08.027
License (as archived): solo-consultazione
Archived: 2026-11-10T07:57:41.993Z
SHA-256 of the archived text: f9a2001cf79f4fd333c911c2cdc48c534574b321a25f6c464c18851598fed237
Stable URL of this page: https://metraipolis.com/documento/dc_ca0bea525946

How to cite

The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection — Europe PMC PMID:41278310 — Europe PMC (en), https://europepmc.org/article/MED/41278310 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca0bea525946 (Metraipolis archive dc_ca0bea525946, sha256 f9a2001cf79f4fd333c911c2cdc48c534574b321a25f6c464c18851598fed237)

BibTeX

@misc{dcca0bea525946,
  title = {The Effects of Clazakizumab on Peripheral Blood and Kidney Transcriptomes in Patients With Late Antibody-Mediated Rejection — Europe PMC PMID:41278310},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41278310},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca0bea525946; sha256 f9a2001cf79f4fd333c911c2cdc48c534574b321a25f6c464c18851598fed237},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41278310. Agents can read the archived copy with the MCP tool read_document.